N-{[3-(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide
Chemical Structure Depiction of
N-{[3-(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide
N-{[3-(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide
Compound characteristics
Compound ID: | G946-0318 |
Compound Name: | N-{[3-(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide |
Molecular Weight: | 560.68 |
Molecular Formula: | C33 H28 N4 O3 S |
Smiles: | CCCN1C(c2ccccc2Sc2cc(ccc12)c1nc(CNC(C(c2ccccc2)c2ccccc2)=O)on1)=O |
Stereo: | ACHIRAL |
logP: | 7.2229 |
logD: | 7.2229 |
logSw: | -5.6617 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 71.135 |
InChI Key: | WKVWJNYBWZXBCQ-UHFFFAOYSA-N |